fashion -WSS

fashion

author：leisure time 2025-09-28 23:29:26 - browse：227

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： UnitedHealth’s board chair also owns a personal investment firm

leisure time

focus

WSS

Hospital price transparency does save money, advocate argues

Elisabeth Bik tackles the widespread issue of research misconduct

Children’s Hospital revives plan for pedestrian bridge

NIH confirmation hearing shows politicization of research

Readout Newsletter: Beam, Prozac, "TechBio" and more

STAT Readout Newsletter: Today's biggest biotech updates

hotspot

fashion

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Will Ozempic

Anesthesiologist group: stop taking Ozempic before surgery

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

How one medical school became remarkably diverse

Pfizer is about to make a big push in cancer. Will investors listen?

Walensky prepares to leave CDC — and Congress — behind

Impact of Dobbs ruling felt at reproductive medicine meeting

In Memoriam: Notable people who died in 2023

Hospital price transparency does save money, advocate argues

hotspot

Hospital price transparency does save money, advocate argues

Study fuels hope CAR

Will Ozempic

Children’s Hospital revives plan for pedestrian bridge

Doctor of U.S. President Joe Biden says he is fit for duty

5 ways to address the shortage of health care workers

leisure time

hotspot

focus

entertainment